Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06494033 · ClinicalTrials.gov registry record
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
A clinical trial of Lung Diseases, sponsored by University of Miami.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06494033: Recruiting study of Lung Diseases, sponsored by University of Miami.
NCT06494033 is a study of Lung Diseases that is actively recruiting participants, run by University of Miami. The registered enrollment target is 100 participants, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06494033, a study of Lung Diseases, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Primary Outcome
Positive CMV Immunoglobulin (IgG) measured by IU/ml
Conditions Studied
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07-03 |
| Est. Completion | 2026-12-30 |
What NCT06494033 shows while recruiting
NCT06494033 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06494033 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06494033 about?
NCT06494033 is a clinical study titled "Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients". The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
What is the current status of trial NCT06494033?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-07-03. Estimated completion is 2026-12-30.
What conditions does trial NCT06494033 study?
This clinical trial studies the following conditions: Lung Diseases.
Who is sponsoring clinical trial NCT06494033?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06494033 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06494033's enrollment target sits among peer trials
100 24th of 31 higher than 6 of 31 other Lung Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
American Lung Association (ALA) Lung Health Cohort
RECRUITING
-
Data Collection Using Eko Digital Devices in a Clinical Setting
RECRUITING
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING · Phase 2
-
Deep Functional Phenotyping of the ALA Lung Health Cohort
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI